The efficacy of the Rességuier method in the treatment of fibromyalgia: a randomised controlled trial
| ISRCTN | ISRCTN62054712 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN62054712 |
| Secondary identifying numbers | N/A |
- Submission date
- 15/12/2008
- Registration date
- 23/12/2008
- Last edited
- 23/12/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English Summary
Not provided at time of registration
Contact information
Dr Susanna Maddali Bongi
Scientific
Scientific
Associazione per lo studio della Sclerosi Sistemica e delle Malattie Fibrosanti (ASSMaF)
Viale Pieraccini 18
Firenze
50139
Italy
Study information
| Study design | Randomised controlled single centre trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Treatment |
| Scientific title | Rehabilitation of fibromyalgia: efficacy of the Rességuier method - a randomised controlled trial |
| Study hypothesis | Rehabilitation holds an important role in the treatment of fibromyalgia syndrome (FMS). Despite numerous studies, an agreement on a specific rehabilitation line, adaptable to the needs of a heterogeneous group of patients, has not been found yet. The Rességuier method is a rehabilitation technique never experimented in fibromyalgia. |
| Ethics approval(s) | Not provided at the time of registration |
| Condition | Fibromyalgia |
| Intervention | FMS patients were recruited and randomly assigned to the Group A and Group B. The patients of Group A were individually treated with the Rességuier method for 8 weeks, 1 session a week. The patients of Group B were observed for 8 weeks. |
| Intervention type | Other |
| Primary outcome measure | 1. Reduction of pain (Numerical Rating Scale [NRS]: 0 - 10) 2. Improvement of disability and quality of life, assessed by the 36-item Short Form (SF-36) Health Survey and Fibromyalgia Impact Questionnaire (FIQ) |
| Secondary outcome measures | 1. Quality of movement (NRS: 0 - 10) 2. Ability to relax mind and body (NRS: 0 - 10) |
| Overall study start date | 10/01/2007 |
| Overall study end date | 10/12/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Other |
| Sex | Both |
| Target number of participants | 36 |
| Participant inclusion criteria | 1. Diagnosis of fibromyalgia according to the American College of Rheumatology (ACR) criteria 2. No age limits |
| Participant exclusion criteria | Does not meet the inclusion criteria |
| Recruitment start date | 10/01/2007 |
| Recruitment end date | 10/12/2007 |
Locations
Countries of recruitment
- Italy
Study participating centre
Associazione per lo studio della Sclerosi Sistemica e delle Malattie Fibrosanti (ASSMaF)
Firenze
50139
Italy
50139
Italy
Sponsor information
University of Florence (Italy)
University/education
University/education
Department of Medicine
Viale GB Morgagni 85
Florence
50134
Italy
| Website | http://www.unifi.it |
|---|---|
"ROR" |
https://ror.org/04jr1s763 |
Funders
Funder type
University/education
University of Florence (Italy) - Department of Medicine
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
